{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:25:25Z","timestamp":1785234325593,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02455-3","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:39:26Z","timestamp":1738993166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic evidence for the liver-brain axis: lipid metabolism and neurodegenerative disease risk"],"prefix":"10.1186","volume":"24","author":[{"given":"Zeyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"2455_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565\u201381.","journal-title":"Nat Rev Neurol"},{"key":"2455_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1289\/ehp.7567","volume":"113","author":"RC Brown","year":"2005","unstructured":"Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect. 2005;113:1250\u20136.","journal-title":"Environ Health Perspect"},{"key":"2455_CR3","doi-asserted-by":"crossref","unstructured":"Kwon HS, Koh S-H. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Translational Neurodegeneration. 2020;9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7689983\/ Cited 2024 Apr 1","DOI":"10.1186\/s40035-020-00221-2"},{"key":"2455_CR4","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu A-G, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, et al. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci. 2022;23:5938.","journal-title":"Int J Mol Sci"},{"key":"2455_CR5","doi-asserted-by":"publisher","first-page":"e13048","DOI":"10.1111\/acel.13048","volume":"18","author":"AA Johnson","year":"2019","unstructured":"Johnson AA, Stolzing A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell. 2019;18:e13048.","journal-title":"Aging Cell"},{"key":"2455_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41392-023-01673-4","volume":"8","author":"M Yan","year":"2023","unstructured":"Yan M, Man S, Sun B, Ma L, Guo L, Huang L, et al. Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal Transduct Target Ther. 2023;8:443.","journal-title":"Signal Transduct Target Ther"},{"key":"2455_CR7","doi-asserted-by":"publisher","first-page":"110439","DOI":"10.1016\/j.biopha.2020.110439","volume":"129","author":"K Kang","year":"2020","unstructured":"Kang K, Xu P, Wang M, Chunyu J, Sun X, Ren G, et al. FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress. Biomed Pharmacother. 2020;129:110439.","journal-title":"Biomed Pharmacother"},{"key":"2455_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","volume":"13","author":"C Xing","year":"2023","unstructured":"Xing C, Huang X, Wang D, Yu D, Hou S, Cui H, et al. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci. 2023;13:106.","journal-title":"Cell Biosci"},{"key":"2455_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s11064-017-2261-5","volume":"42","author":"JE Sperringer","year":"2017","unstructured":"Sperringer JE, Addington A, Hutson SM. Branched-Chain Amino Acids and Brain Metabolism. Neurochem Res. 2017;42:1697\u2013709.","journal-title":"Neurochem Res"},{"key":"2455_CR10","doi-asserted-by":"crossref","unstructured":"Loving BA, Bruce KD. Lipid and Lipoprotein Metabolism in Microglia. Front Physiol. 2020;11. Available from: https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2020.00393\/full. Cited 2024 Apr 1","DOI":"10.3389\/fphys.2020.00393"},{"key":"2455_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bbalip.2015.02.007","volume":"1851","author":"G Dawson","year":"2015","unstructured":"Dawson G. Measuring brain lipids. Biochimica et Biophysica Acta (BBA) - Mol Cell Biol Lipids. 2015;1851:1026\u201339.","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Cell Biol Lipids."},{"key":"2455_CR12","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.clnu.2019.10.017","volume":"39","author":"Q Xu","year":"2020","unstructured":"Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, et al. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer\u2019s disease patients with APOE4\u2212\/\u2212: A double-blind, randomized, placebo-controlled crossover trial. Clin Nutr. 2020;39:2092\u2013105.","journal-title":"Clin Nutr"},{"key":"2455_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.14336\/AD.2015.1030","volume":"7","author":"NW Sterling","year":"2016","unstructured":"Sterling NW, Lichtenstein M, Lee E-Y, Lewis MM, Evans A, Eslinger PJ, et al. Higher plasma LDL-cholesterol is associated with preserved executive and fine motor functions in Parkinson\u2019s Disease. Aging Dis. 2016;7:237\u201345.","journal-title":"Aging Dis"},{"key":"2455_CR14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mds.27609","volume":"34","author":"X Huang","year":"2019","unstructured":"Huang X, Sterling NW, Du G, Sun D, Stetter C, Kong L, et al. Brain cholesterol metabolism and Parkinson\u2019s disease. Mov Disord. 2019;34:386\u201395.","journal-title":"Mov Disord"},{"key":"2455_CR15","doi-asserted-by":"publisher","first-page":"j1648","DOI":"10.1136\/bmj.j1648","volume":"357","author":"M Benn","year":"2017","unstructured":"Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybj\u00e6rg-Hansen A. Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: Mendelian randomisation study. BMJ. 2017;357:j1648.","journal-title":"BMJ"},{"key":"2455_CR16","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1212\/01.wnl.0000312511.62699.a8","volume":"70","author":"G Hu","year":"2008","unstructured":"Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology. 2008;70:1972\u20139.","journal-title":"Neurology"},{"key":"2455_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbi.2021.10.014","volume":"99","author":"P-Y Lin","year":"2022","unstructured":"Lin P-Y, Cheng C, Satyanarayanan SK, Chiu L-T, Chien Y-C, Chuu C-P, et al. Omega-3 fatty acids and blood-based biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: A randomized placebo-controlled trial. Brain Behav Immun. 2022;99:289\u201398.","journal-title":"Brain Behav Immun"},{"key":"2455_CR18","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey SG. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27:R195-208.","journal-title":"Hum Mol Genet"},{"key":"2455_CR19","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89-98.","journal-title":"Hum Mol Genet"},{"key":"2455_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","volume":"628","author":"MK Karjalainen","year":"2024","unstructured":"Karjalainen MK, Karthikeyan S, Oliver-Williams C, Sliz E, Allara E, Fung WT, et al. Genome-wide characterization of circulating metabolic biomarkers. Nature. 2024;628:130\u20138.","journal-title":"Nature"},{"key":"2455_CR21","doi-asserted-by":"publisher","first-page":"108915","DOI":"10.1016\/j.neuropharm.2021.108915","volume":"205","author":"Y Matsubara","year":"2022","unstructured":"Matsubara Y, Kiyohara H, Teratani T, Mikami Y, Kanai T. Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases. Neuropharmacology. 2022;205:108915.","journal-title":"Neuropharmacology"},{"key":"2455_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Bu X-L, Liu Y-H, Zhu C, Shen L-L, Jiao S-S, et al. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol. 2015;130:487\u201399.","journal-title":"Acta Neuropathol"},{"key":"2455_CR23","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","volume":"111","author":"Y Wu","year":"2023","unstructured":"Wu Y, Dong J-H, Dai Y-F, Zhu M-Z, Wang M-Y, Zhang Y, et al. Hepatic soluble epoxide hydrolase activity regulates cerebral A\u03b2 metabolism and the pathogenesis of Alzheimer\u2019s disease in mice. Neuron. 2023;111:2847-2862.e10.","journal-title":"Neuron"},{"key":"2455_CR24","doi-asserted-by":"publisher","first-page":"G749","DOI":"10.1152\/ajpgi.00184.2011","volume":"301","author":"C D\u2019Mello","year":"2011","unstructured":"D\u2019Mello C, Swain MG. Liver-brain inflammation axis. Am J Physiol Gastrointest Liver Physiol. 2011;301:G749-761.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2455_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1034\/j.1600-0404.2002.01334.x","volume":"106","author":"F Giubilei","year":"2002","unstructured":"Giubilei F, Antonini G, Di Legge S, Sormani MP, Pantano P, Antonini R, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand. 2002;106:109\u201312.","journal-title":"Acta Neurol Scand"},{"key":"2455_CR26","doi-asserted-by":"publisher","first-page":"114378","DOI":"10.1016\/j.biopha.2023.114378","volume":"160","author":"AHME Ketabforoush","year":"2023","unstructured":"Ketabforoush AHME, Chegini R, Barati S, Tahmasebi F, Moghisseh B, Joghataei MT, et al. Masitinib: the promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series. Biomed Pharmacother. 2023;160:114378.","journal-title":"Biomed Pharmacother"},{"key":"2455_CR27","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","volume":"145","author":"J Galper","year":"2022","unstructured":"Galper J, Dean NJ, Pickford R, Lewis SJG, Halliday GM, Kim WS, et al. Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease. Brain. 2022;145:3472\u201387.","journal-title":"Brain"},{"key":"2455_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneuroim.2012.01.002","volume":"248","author":"FJ Quintana","year":"2012","unstructured":"Quintana FJ, Yeste A, Weiner HL, Covacu R. Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis. J Neuroimmunol. 2012;248:53\u20137.","journal-title":"J Neuroimmunol"},{"key":"2455_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.neurobiolaging.2008.05.025","volume":"31","author":"J Infante","year":"2010","unstructured":"Infante J, Rodr\u00edguez-Rodr\u00edguez E, Mateo I, Llorca J, V\u00e1zquez-Higuera JL, Berciano J, et al. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer\u2019s disease risk. Neurobiol Aging. 2010;31:710\u20134.","journal-title":"Neurobiol Aging"},{"key":"2455_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2016.10.008","volume":"101","author":"M Doria","year":"2016","unstructured":"Doria M, Maugest L, Moreau T, Lizard G, Vejux A. Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson\u2019s disease. Free Radic Biol Med. 2016;101:393\u2013400.","journal-title":"Free Radic Biol Med"},{"key":"2455_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12974-018-1114-8","volume":"15","author":"V Mutemberezi","year":"2018","unstructured":"Mutemberezi V, Buisseret B, Masquelier J, Guillemot-Legris O, Alhouayek M, Muccioli GG. Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models. J Neuroinflammation. 2018;15:74.","journal-title":"J Neuroinflammation"},{"key":"2455_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnmol.2018.00012","volume":"11","author":"A Vejux","year":"2018","unstructured":"Vejux A, Namsi A, Nury T, Moreau T, Lizard G. Biomarkers of amyotrophic lateral sclerosis: current status and interest of oxysterols and phytosterols. Front Mol Neurosci. 2018;11:12.","journal-title":"Front Mol Neurosci"},{"key":"2455_CR33","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;13:1310.","journal-title":"Front Neurosci"},{"key":"2455_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","volume":"9","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617\u201328.","journal-title":"Nat Rev Neurol"},{"key":"2455_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S-C Ling","year":"2013","unstructured":"Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416\u201338.","journal-title":"Neuron"},{"key":"2455_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00415-009-5100-z","volume":"256","author":"C Bouteloup","year":"2009","unstructured":"Bouteloup C, Desport J-C, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256:1236\u201342.","journal-title":"J Neurol"},{"key":"2455_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","volume":"74","author":"JC Desport","year":"2001","unstructured":"Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufr\u00e8re B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328\u201334.","journal-title":"Am J Clin Nutr"},{"key":"2455_CR38","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/glia.23825","volume":"68","author":"KM Guzman","year":"2020","unstructured":"Guzman KM, Brink LE, Rodriguez-Bey G, Bodnar RJ, Kuang L, Xing B, et al. Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation. Glia. 2020;68:2040\u201356.","journal-title":"Glia"},{"key":"2455_CR39","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1074\/jbc.M114.576652","volume":"289","author":"LL Morris","year":"2014","unstructured":"Morris LL, Hartman IZ, Jun D-J, Seemann J, DeBose-Boyd RA. Sequential actions of the AAA-ATPase valosin-containing protein (VCP)\/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. J Biol Chem. 2014;289:19053\u201366.","journal-title":"J Biol Chem"},{"key":"2455_CR40","doi-asserted-by":"publisher","first-page":"105289","DOI":"10.1016\/j.nbd.2021.105289","volume":"152","author":"J Canet-Pons","year":"2021","unstructured":"Canet-Pons J, Sen N-E, Arsovi\u0107 A, Almaguer-Mederos L-E, Halbach MV, Key J, et al. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol Dis. 2021;152:105289.","journal-title":"Neurobiol Dis"},{"key":"2455_CR41","doi-asserted-by":"publisher","first-page":"e201910213","DOI":"10.1083\/jcb.201910213","volume":"220","author":"WY Ho","year":"2021","unstructured":"Ho WY, Chang J-C, Lim K, Cazenave-Gassiot A, Nguyen AT, Foo JC, et al. TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination. J Cell Biol. 2021;220:e201910213.","journal-title":"J Cell Biol"},{"key":"2455_CR42","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2169\/internalmedicine.51.7465","volume":"51","author":"K Ikeda","year":"2012","unstructured":"Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern Med. 2012;51:1501\u20138.","journal-title":"Intern Med"},{"key":"2455_CR43","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3109\/21678421.2015.1062517","volume":"16","author":"MK Rafiq","year":"2015","unstructured":"Rafiq MK, Lee E, Bradburn M, McDermott CJ, Shaw PJ. Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:478\u201384.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2455_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jns.2017.07.019","volume":"380","author":"JB Delaye","year":"2017","unstructured":"Delaye JB, Patin F, Piver E, Bruno C, Vasse M, Vourc\u2018h P, et al. Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients. J Neurol Sci. 2017;380:124\u20137.","journal-title":"J Neurol Sci."},{"key":"2455_CR45","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis L, Corcia P, Fergani A, De Gonzalez Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004\u20139.","journal-title":"Neurology."},{"key":"2455_CR46","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.0b013e3181c1df1e","volume":"73","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2 A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2009;73:1681\u20135.","journal-title":"Neurology"},{"key":"2455_CR47","doi-asserted-by":"publisher","first-page":"11855","DOI":"10.18632\/oncotarget.14416","volume":"8","author":"S-M Kim","year":"2017","unstructured":"Kim S-M, Noh M-Y, Kim H, Cheon S-Y, Lee KM, Lee J, et al. 25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis. Oncotarget. 2017;8:11855\u201367.","journal-title":"Oncotarget"},{"key":"2455_CR48","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","volume":"81","author":"D Mariosa","year":"2017","unstructured":"Mariosa D, Hammar N, Malmstr\u00f6m H, Ingre C, Jungner I, Ye W, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017;81:718\u201328.","journal-title":"Ann Neurol"},{"key":"2455_CR49","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.3390\/ijms24108675","volume":"24","author":"T Pardo-Moreno","year":"2023","unstructured":"Pardo-Moreno T, Mohamed-Mohamed H, Suleiman-Martos S, Ramos-Rodriguez JJ, Rivas-Dominguez A, Melguizo-Rodr\u00edguez L, et al. Amyotrophic lateral sclerosis and serum lipid level association: a systematic review and meta-analytic study. Int J Mol Sci. 2023;24:8675.","journal-title":"Int J Mol Sci"},{"key":"2455_CR50","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/ene.15810","volume":"30","author":"K Xia","year":"2023","unstructured":"Xia K, Klose V, H\u00f6gel J, Huang T, Zhang L, Dorst J, et al. Lipids and amyotrophic lateral sclerosis: A two-sample Mendelian randomization study. Eur J Neurol. 2023;30:1899\u2013906.","journal-title":"Eur J Neurol"},{"key":"2455_CR51","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen W, van der Spek RAA, Bakker MK, van Vugt JJFA, Hop PJ, Zwamborn RAJ, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53:1636\u201348.","journal-title":"Nat Genet"},{"key":"2455_CR52","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1194\/jlr.R900015-JLR200","volume":"50","author":"AN Hoofnagle","year":"2009","unstructured":"Hoofnagle AN, Heinecke JW. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J Lipid Res. 2009;50:1967\u201375.","journal-title":"J Lipid Res"},{"key":"2455_CR53","doi-asserted-by":"publisher","first-page":"e025858","DOI":"10.1161\/JAHA.122.025858","volume":"11","author":"T Glavinovic","year":"2022","unstructured":"Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD. Physiological bases for the superiority of apolipoprotein B over low-density lipoprotein cholesterol and non\u2013high-density lipoprotein cholesterol as a marker of cardiovascular risk. J Am Heart Assoc. 2022;11:e025858.","journal-title":"J Am Heart Assoc"},{"key":"2455_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12944-023-01857-5","volume":"22","author":"S Kim","year":"2023","unstructured":"Kim S, Lee J-W, Lee Y, Song Y, Linton JA. Association between triglyceride-glucose index and low-density lipoprotein particle size in korean obese adults. Lipids Health Dis. 2023;22:94.","journal-title":"Lipids Health Dis"},{"key":"2455_CR55","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/biomedicines10051105","volume":"10","author":"JM Godoy-Corchuelo","year":"2022","unstructured":"Godoy-Corchuelo JM, Fern\u00e1ndez-Beltr\u00e1n LC, Ali Z, Gil-Moreno MJ, L\u00f3pez-Carbonero JI, Guerrero-Sola A, et al. Lipid metabolic alterations in the ALS\u2013FTD spectrum of disorders. Biomedicines. 2022;10:1105.","journal-title":"Biomedicines"},{"key":"2455_CR56","doi-asserted-by":"publisher","first-page":"e2009808118","DOI":"10.1073\/pnas.2009808118","volume":"118","author":"J Lord","year":"2021","unstructured":"Lord J, Jermy B, Green R, Wong A, Xu J, Legido-Quigley C, et al. Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2021;118:e2009808118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2455_CR57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/JAD-220050","volume":"87","author":"S-Y Huang","year":"2022","unstructured":"Huang S-Y, Yang Y-X, Zhang Y-R, Kuo K, Li H-Q, Shen X-N, et al. Investigating causal relations between circulating metabolites and alzheimer\u2019s disease: a Mendelian randomization study. J Alzheimers Dis. 2022;87:463\u201377.","journal-title":"J Alzheimers Dis"},{"key":"2455_CR58","doi-asserted-by":"publisher","first-page":"578105","DOI":"10.1016\/j.jneuroim.2023.578105","volume":"379","author":"A Ge","year":"2023","unstructured":"Ge A, Sun Y, Kiker T, Zhou Y, Ye K. A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis. J Neuroimmunol. 2023;379:578105.","journal-title":"J Neuroimmunol"},{"key":"2455_CR59","doi-asserted-by":"publisher","first-page":"e066334","DOI":"10.1002\/alz.066334","volume":"19","author":"K Pham","year":"2023","unstructured":"Pham K, Mulugeta A, Lumsden A, Hypp\u00f6nen E. A multivariable mendelian randomisation study of serum lipids and dementia risk within the UK Biobank. Alzheimer\u2019s Dementia. 2023;19:e066334.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"2455_CR60","doi-asserted-by":"publisher","first-page":"113634","DOI":"10.1016\/j.biopha.2022.113634","volume":"154","author":"AS Bhale","year":"2022","unstructured":"Bhale AS, Venkataraman K. Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeutics. Biomed Pharmacother. 2022;154:113634.","journal-title":"Biomed Pharmacother"},{"key":"2455_CR61","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","volume":"4","author":"AD Sniderman","year":"2019","unstructured":"Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano A, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4:1287\u201395.","journal-title":"JAMA Cardiol"},{"key":"2455_CR62","doi-asserted-by":"publisher","first-page":"e2313734","DOI":"10.1001\/jamanetworkopen.2023.13734","volume":"6","author":"J Luo","year":"2023","unstructured":"European Alzheimer\u2019s & Dementia Biobank Mendelian Randomization (EADB-MR) Collaboration, Luo J, Thomassen JQ, Bellenguez C, Grenier-Boley B, de Rojas I, et al. Genetic associations between modifiable risk factors and alzheimer disease. JAMA Netw Open. 2023;6:e2313734.","journal-title":"JAMA Netw Open."},{"key":"2455_CR63","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamaneurol.2019.0648","volume":"76","author":"TS Wingo","year":"2019","unstructured":"Wingo TS, Cutler DJ, Wingo AP, Le N-A, Rabinovici GD, Miller BL, et al. Association of early-onset alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic coding variants of APOB. JAMA Neurol. 2019;76:809\u201317.","journal-title":"JAMA Neurol"},{"key":"2455_CR64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF02535114","volume":"17","author":"RB Ramsey","year":"1982","unstructured":"Ramsey RB, Nicholas HJ. Unusual urinary cholesterol metabolites following intracerebral injection of [4\u201314C]cholesterol into rats: I. The minor 14C-metabolite. Lipids. 1982;17:263\u20137.","journal-title":"Lipids."},{"key":"2455_CR65","doi-asserted-by":"publisher","first-page":"109030","DOI":"10.1016\/j.abb.2021.109030","volume":"712","author":"S Pashaei","year":"2021","unstructured":"Pashaei S, Mohammadi P, Yarani R, Haghgoo SM, Emami Aleagha MS. Carbohydrate and lipid metabolism in multiple sclerosis: Clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy. Arch Biochem Biophys. 2021;712:109030.","journal-title":"Arch Biochem Biophys"},{"key":"2455_CR66","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1742-2094-8-127","volume":"8","author":"B Weinstock-Guttman","year":"2011","unstructured":"Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation. 2011;8:127.","journal-title":"J Neuroinflammation"},{"key":"2455_CR67","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 1998;273:9443\u20139.","journal-title":"J Biol Chem"},{"key":"2455_CR68","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.3390\/ijms22147630","volume":"22","author":"M Fais","year":"2021","unstructured":"Fais M, Dore A, Galioto M, Galleri G, Crosio C, Iaccarino C. Parkinson\u2019s disease-related genes and lipid alteration. Int J Mol Sci. 2021;22:7630.","journal-title":"Int J Mol Sci"},{"key":"2455_CR69","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/cells8040364","volume":"8","author":"GM Riboldi","year":"2019","unstructured":"Riboldi GM, Di Fonzo AB. GBA, Gaucher disease, and Parkinson\u2019s disease: from genetic to clinic to new therapeutic approaches. Cells. 2019;8:364.","journal-title":"Cells"},{"key":"2455_CR70","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/BST20180462","volume":"47","author":"JH Kluss","year":"2019","unstructured":"Kluss JH, Mamais A, Cookson MR. LRRK2 links genetic and sporadic Parkinson\u2019s disease. Biochem Soc Trans. 2019;47:651\u201361.","journal-title":"Biochem Soc Trans"},{"key":"2455_CR71","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","volume":"16","author":"L Correia Guedes","year":"2010","unstructured":"Correia Guedes L, Ferreira JJ, Rosa MM, Coelho M, Bonifati V, Sampaio C. Worldwide frequency of G2019S LRRK2 mutation in Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord. 2010;16:237\u201342.","journal-title":"Parkinsonism Relat Disord"},{"key":"2455_CR72","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/ana.25880","volume":"88","author":"DM Williams","year":"2020","unstructured":"Williams DM, Bandres-Ciga S, Heilbron K, Hinds D, Noyce AJ, 23andMe Research Team, et al. Evaluating lipid-lowering drug targets for Parkinson\u2019s disease prevention with Mendelian randomization. Ann Neurol. 2020;88:1043\u20137.","journal-title":"Ann Neurol."},{"key":"2455_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14802\/jmd.22175","volume":"16","author":"KW Park","year":"2023","unstructured":"Park KW, Hwang YS, Lee SH, Jo S, Chung SJ. The effect of blood lipids, type 2 diabetes, and body mass index on Parkinson\u2019s Disease: a Korean Mendelian randomization study. J Mov Disord. 2023;16:79\u201385.","journal-title":"J Mov Disord"},{"key":"2455_CR74","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1038\/s41467-024-50565-w","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Yang Z, Satoshi F, Prasanna X, Yan Z, Vihinen H, et al. Membrane remodeling by FAM92A1 during brain development regulates neuronal morphology, synaptic function, and cognition. Nat Commun. 2024;15:6209.","journal-title":"Nat Commun"},{"key":"2455_CR75","doi-asserted-by":"publisher","first-page":"106313","DOI":"10.1016\/j.nbd.2023.106313","volume":"187","author":"K Shing","year":"2023","unstructured":"Shing K, Sapp E, Boudi A, Liu S, Seeley C, Marchionini D, et al. Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model. Neurobiol Dis. 2023;187:106313.","journal-title":"Neurobiol Dis"},{"key":"2455_CR76","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1021\/acschemneuro.3c00823","volume":"15","author":"LS Kalinichenko","year":"2024","unstructured":"Kalinichenko LS, Kornhuber J, Sinning S, Haase J, M\u00fcller CP. Serotonin signaling through lipid membranes. ACS Chem Neurosci. 2024;15:1298\u2013320.","journal-title":"ACS Chem Neurosci"},{"key":"2455_CR77","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s42255-023-00756-4","volume":"5","author":"Y Mi","year":"2023","unstructured":"Mi Y, Qi G, Vitali F, Shang Y, Raikes AC, Wang T, et al. Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration. Nat Metab. 2023;5:445\u201365.","journal-title":"Nat Metab"},{"key":"2455_CR78","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.smim.2022.101594","volume":"59","author":"S Parhizkar","year":"2022","unstructured":"Parhizkar S, Holtzman DM. APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s Disease. Semin Immunol. 2022;59:101594.","journal-title":"Semin Immunol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02455-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02455-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02455-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T06:22:28Z","timestamp":1738995748000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02455-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2455"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02455-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}